Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Impact of Cardiometabolic Risk Factors Control on Cardiovascular-Kidney-Metabolic Axis in Chronic Hepatitis B.

BACKGROUND The impact of cardiometabolic risk factors (CMRFs) on the cardiovascular-kidney-metabolic (CKM) axis in chronic hepatitis B (CHB) remains poorly defined. METHODS We conducted a prospective analysis enrolling patients with CHB who were on nucleos(t)ide analogues (NUCs). CMRFs were defined as per established...

K. Ho, R. Hui, Matthew Shing-Hin Chung et al. · 0 citations
Review Sep 2026

Occult hepatitis B virus infection.

L. Mak, R. Hui, T. Pollicino et al. · 0 citations
Review Open access Oct 2026

Clinical Prospect of Novel Therapies for Functional Cure in Chronic Hepatitis B.

RNA-targeting therapies and combination regimens offer promising approaches in attaining functional cure in CHB, with bepirovirsen (an unconjugated antisense oligonucleotide) standing out as the only agent completed in Phase III study showing efficacious results.

K. Ho, R. Hui, L. Mak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.